Lawrence Otto Klein sold $6.9M of Oruka Therapeutics (ORKA)

Executed Sep 1, disclosed Sep 1, the same day.

Value, as filed

$6.9M

75,000 sh across 3 lots

Executed

Sep 1

the trade date, as filed

Disclosed

Sep 1

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Lawrence Otto Klein Chief Executive Officer profile →

Lawrence Otto Klein (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $6.9M of ORKA (75,000 sh across 3 lots, as filed), executed Sep 1.

The name

ORKA

Oruka Therapeutics, Inc. ORKA · Healthcare · 32 filings in 24 months ticker →

Healthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Lawrence Otto Klein in ORKA

ORKASALE Oruka Therapeutics, Inc. $2.3M
23,944 sh across 3 lots
Exec Nov 2
Filed Nov 2 · 5:46 PM ET ORKASALE Oruka Therapeutics, Inc. $2.1M
24,800 sh across 2 lots
Exec Oct 1
Filed Oct 2 · 7:54 PM ET ORKASALE Oruka Therapeutics, Inc. $235K
2,452 sh × $95.71
Exec Sep 15
Filed Sep 15 · 7:15 PM ET ORKASALE Oruka Therapeutics, Inc. $120K
1,729 sh × $69.69
Exec Jun 15
Filed Jun 15 · 5:30 PM ET